Precision Biosciences (DTIL) Other Accumulated Expenses (2019 - 2026)

Precision Biosciences (DTIL) has 8 years of Other Accumulated Expenses data on file, last reported at $858000.0 in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 4.24% year-over-year to $858000.0 in Q1 2026; TTM through Mar 2026 was $858000.0, a 4.24% decrease from a year earlier, with the FY2025 full-year figure at $649000.0, down 34.38% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $858000.0, up from $649000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for DTIL reached as high as $2.8 million in Q1 2024 and fell as low as $611000.0 in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $1.3 million across 5 years, with a median of $1.2 million in 2022.
• Across the five-year window, Other Accumulated Expenses soared 220.94% in 2023 and sank 67.68% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $745000.0 in 2022, then surged by 220.94% to $2.4 million in 2023, then plunged by 58.64% to $989000.0 in 2024, then slumped by 34.38% to $649000.0 in 2025, then surged by 32.2% to $858000.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $858000.0 in Q1 2026, $649000.0 in Q4 2025, and $611000.0 in Q3 2025.